GH1 and Turner syndrome: Median (Q1–Q3) starting GH dose for patients overall was 0.23 (0.19–0.26) mg/kg/week; starting dose was higher for patients with Turner syndrome, 0.30 (0.26–0.34) mg/kg/week, and for the 2 patients with chronic renal insufficiency, 0.31 (0.28–0.34) mg/kg/week, but similar across the other diagnostic categories.